DENTSPLY SIRONA (XRAY) and Zimmer Biomet Holdings (ZBH) Critical Comparison
DENTSPLY SIRONA (NASDAQ: XRAY) and Zimmer Biomet Holdings (NYSE:ZBH) are both large-cap medical equipment, supplies & distribution – nec companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, valuation, analyst recommendations, earnings, institutional ownership, risk and dividends.
This is a summary of current ratings and target prices for DENTSPLY SIRONA and Zimmer Biomet Holdings, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Zimmer Biomet Holdings||1||7||12||1||2.62|
DENTSPLY SIRONA currently has a consensus price target of $65.63, indicating a potential upside of 1.27%. Zimmer Biomet Holdings has a consensus price target of $136.58, indicating a potential upside of 25.02%. Given Zimmer Biomet Holdings’ stronger consensus rating and higher probable upside, analysts plainly believe Zimmer Biomet Holdings is more favorable than DENTSPLY SIRONA.
Earnings and Valuation
This table compares DENTSPLY SIRONA and Zimmer Biomet Holdings’ gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||NetIncome||Earnings Per Share||Price/Earnings Ratio|
|DENTSPLY SIRONA||$3.75 billion||3.97||$429.90 million||($3.48)||-18.62|
|Zimmer Biomet Holdings||$7.68 billion||2.87||$305.90 million||$3.21||34.03|
DENTSPLY SIRONA has higher revenue, but lower earnings than Zimmer Biomet Holdings. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Zimmer Biomet Holdings, indicating that it is currently the more affordable of the two stocks.
This table compares DENTSPLY SIRONA and Zimmer Biomet Holdings’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Zimmer Biomet Holdings||8.36%||16.29%||6.17%|
Volatility and Risk
DENTSPLY SIRONA has a beta of 1.27, suggesting that its share price is 27% more volatile than the S&P 500. Comparatively, Zimmer Biomet Holdings has a beta of 1.17, suggesting that its share price is 17% more volatile than the S&P 500.
DENTSPLY SIRONA pays an annual dividend of $0.35 per share and has a dividend yield of 0.5%. Zimmer Biomet Holdings pays an annual dividend of $0.96 per share and has a dividend yield of 0.9%. DENTSPLY SIRONA pays out -10.1% of its earnings in the form of a dividend. Zimmer Biomet Holdings pays out 29.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.
Insider and Institutional Ownership
93.9% of DENTSPLY SIRONA shares are held by institutional investors. Comparatively, 85.3% of Zimmer Biomet Holdings shares are held by institutional investors. 2.0% of DENTSPLY SIRONA shares are held by insiders. Comparatively, 1.1% of Zimmer Biomet Holdings shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Zimmer Biomet Holdings beats DENTSPLY SIRONA on 10 of the 17 factors compared between the two stocks.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc. is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies. The dental industry encompasses the diagnosis, treatment and prevention of disease and ailments of the teeth, gums and supporting bone. Its principal dental product categories are dental consumable products, dental laboratory products, dental specialty products and dental equipment. Additionally, its consumable medical device products are used for urological and surgical applications. These products are produced by the Company in the United States and internationally and are distributed throughout the world under various brand names, including ANKYLOS, AQUASIL ULTRA, ARTICADENT, ATLANTIS, CALIBRA, CAULK, CAVITRON, CELTRA, DELTON, DENTSPLY, DETREY and DYRACT.
About Zimmer Biomet Holdings
Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company’s products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consisting principally of the United States and other North, Central and South American markets; EMEA, consisting principally of Europe and the Middle East and African markets, and Asia Pacific, consisting primarily of Japan and other Asian and Pacific markets. The Company’s product category segments include Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic (CMF), and Dental.
Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.